Biofield Pharma Private Limited

Composition (per tablet):

• Nimesulide 100 mg – NSAID (pain & inflammation relief)

• Paracetamol 325 mg – Pain & fever reducer

• Phenylephrine HCl 10 mg – Nasal decongestant

• Caffeine (Anhydrous) 25 mg – Enhances pain relief & reduces fatigue

Relief of symptoms associated with:

• Common cold

• Flu

• Sinusitis

• Fever

• Headache

• Body aches

• Nasal congestion

• Nimesulide + Paracetamol → Reduce fever and body pain

• Phenylephrine → Clears blocked nose

• Caffeine → Boosts alertness and improves effectiveness of painkillers

• 1 tablet twice daily after food

• Use for short duration (generally 3–5 days)

• Nausea

• Stomach discomfort

• Dizziness

• Increased blood pressure

• Insomnia (due to caffeine)

• Not recommended in liver disease

• Avoid alcohol

• Do not combine with other paracetamol-containing medicines

• Use cautiously in hypertension and heart disease

• Not advised for children unless prescribed

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 DAYS
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

DRESCAP 20 is an advanced anti-allergic formulation containing Desloratadine 20 mg, designed for effective relief from allergic rhinitis, urticaria, and other histamine-mediated conditions. It provides long-lasting, non-sedating allergy control with improved patient comfort and compliance.

Manufactured in a WHO-GMP compliant facility using high-quality APIs and pharmacopeial-grade excipients, DRESCAP 20 ensures consistent potency, optimal bioavailability, and superior quality standards — making it suitable for PCD Pharma Franchise, third-party manufacturing, and export markets.

Desloratadine (20 mg):
A second-generation, selective H1-receptor antagonist that blocks the action of histamine — the primary mediator responsible for allergic symptoms.

By inhibiting peripheral histamine receptors, Desloratadine effectively reduces sneezing, runny nose, nasal itching, watery eyes, and skin rashes without causing significant sedation. It offers prolonged duration of action, supporting once-daily dosing as prescribed.

Its non-drowsy profile makes it suitable for daytime use and improved patient adherence.

✅ Long-Lasting Anti-Allergic Relief
✅ Non-Sedating Second-Generation Antihistamine
✅ Effective for Allergic Rhinitis & Urticaria
✅ Reduces Sneezing, Itching & Watery Eyes
✅ Once-Daily Dosing (as prescribed)
✅ WHO-GMP Manufactured
✅ Suitable for PCD Pharma & Third-Party Manufacturing
✅ Export-Quality Standards

✔️ Patients with seasonal allergic rhinitis
✔️ Perennial allergic rhinitis
✔️ Chronic idiopathic urticaria (hives)
✔️ Skin allergies with itching and redness
✔️ General physicians & allergists
✔️ Pharmacies, distributors, stockists & international buyers

Mild headache
Dry mouth
Fatigue (rare)
Gastrointestinal discomfort

⚠️ Use under medical supervision. Caution in patients with severe hepatic impairment. Follow prescribed dosage strictly.

✅ High-Quality API & Excipients: Sourced from validated vendors ensuring purity and efficacy.
✅ Strict Quality Control: Manufactured under WHO-GMP standards with validated production systems.
✅ Uniform Dosage Accuracy: Ensures consistent therapeutic effect in every tablet/capsule.
✅ Microbial & Contamination Control: Produced in controlled environments with stringent quality checks.
✅ Premium Packaging Options: Protective packaging ensuring product stability and shelf life.
✅ After-Sales Technical Support: Regulatory, marketing, and documentation assistance for domestic and export markets.

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

EBAGRIP-M is a clinically advanced anti-allergic combination formulated with Ebastine 10 mg + Montelukast 10 mg Tablets, designed for effective management of allergic rhinitis and associated respiratory allergic disorders. It provides dual-pathway control by targeting both histamine and leukotriene-mediated inflammatory responses, ensuring sustained symptom relief and improved quality of life.

Manufactured in a WHO-GMP compliant facility using high-quality APIs and pharmacopeial-grade excipients, EBAGRIP-M ensures uniform drug dispersion, consistent therapeutic performance, and enhanced patient compliance — making it suitable for PCD Pharma Franchise, third-party manufacturing, and export markets.

Ebastine (10 mg):
A second-generation, long-acting H1 antihistamine that selectively blocks peripheral histamine receptors. It effectively reduces sneezing, nasal discharge, itching, watery eyes, and other allergy-related symptoms without causing significant sedation.

Montelukast (10 mg):
A selective leukotriene receptor antagonist (LTRA) that inhibits cysteinyl leukotriene receptors in the respiratory tract. Leukotrienes contribute to nasal congestion, airway inflammation, and hypersensitivity reactions.

The synergistic combination offers comprehensive control of both early allergic responses (histamine-mediated) and late-phase inflammation (leukotriene-mediated), making it particularly beneficial in persistent and moderate allergic conditions.

✅ Dual-Action Formula: Antihistamine + Leukotriene Blocker
✅ Effective Relief from Allergic Rhinitis
✅ Reduces Sneezing, Nasal Congestion & Itching
✅ Supports Control of Allergy-Associated Respiratory Symptoms
✅ Non-Sedating & Long-Acting Relief
✅ Once-Daily Dosing (as prescribed)
✅ WHO-GMP Manufactured
✅ Suitable for PCD Pharma & Third-Party Manufacturing
✅ Export-Quality Standards

✔️ Seasonal allergic rhinitis
✔️ Perennial allergic rhinitis
✔️ Allergic rhinitis with nasal blockage
✔️ Patients with allergy-associated airway inflammation
✔️ General physicians, ENT specialists & pulmonologists
✔️ Pharmacies, distributors, stockists & international buyers

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

EBAGRIP-10 is a scientifically formulated anti-allergic tablet containing Ebastine 10 mg, a second-generation antihistamine designed for effective and long-lasting relief from allergic conditions. It provides 24-hour symptom control with minimal sedation, making it suitable for daily use in patients suffering from allergic rhinitis and chronic urticaria.

Manufactured in a WHO-GMP compliant facility following stringent quality assurance protocols, EBAGRIP-10 ensures high purity, consistent potency, and superior patient compliance. It is an ideal product for PCD Pharma Franchise, third-party manufacturing, and export markets.

Ebastine 10 mg:
Ebastine is a long-acting H1-receptor antagonist that blocks the action of histamine, the key mediator responsible for allergic symptoms such as sneezing, nasal congestion, itching, watery eyes, and skin rashes.

After oral administration, Ebastine is rapidly metabolized into its active metabolite, carebastine, which provides prolonged antihistaminic activity without significant central nervous system penetration—resulting in minimal drowsiness compared to first-generation antihistamines.

This targeted mechanism ensures effective symptom relief, improved breathing comfort, and enhanced quality of life for allergic patients.

✅ 24-Hour Relief from Allergic Symptoms
✅ Non-Sedating / Minimal Drowsiness Formula
✅ Effective in Allergic Rhinitis & Chronic Urticaria
✅ Rapid Onset & Long-Lasting Action
✅ Improves Nasal Congestion, Sneezing & Itching
✅ Suitable for Long-Term Allergy Management
✅ Manufactured in WHO-GMP Certified Facility
✅ PCD Pharma & Third-Party Manufacturing Ready
✅ Export-Quality Production Standards

✔️ Patients suffering from seasonal allergic rhinitis (hay fever)
✔️ Individuals with perennial allergic rhinitis
✔️ Patients experiencing chronic idiopathic urticaria
✔️ People with recurrent sneezing, nasal congestion & watery eyes
✔️ Patients prone to allergic skin rashes & itching
✔️ Suitable for wholesalers, stockists, and international importers

Mild headache
Dry mouth
Occasional drowsiness
Gastrointestinal discomfort (rare)

⚠️ Use under medical supervision in patients with hepatic impairment. Consult a physician before use during pregnancy or lactation.

✅ High-Quality API & Excipients: We use pharmacopeial-grade Ebastine with validated analytical testing to ensure purity and stability.
✅ Stringent Quality Control: Manufactured under WHO-GMP guidelines with in-process quality checks and batch traceability.
✅ Advanced Manufacturing Infrastructure: Controlled production environment with proper air handling and cross-contamination prevention.
✅ Regulatory Compliance: Documentation support for domestic marketing and export registration.
✅ Premium Blister Packaging: Ensures product stability, moisture protection, and extended shelf life.

✔️ PCD Pharma Franchise for Anti-Allergic Tablets
✔️ Third-Party Manufacturing of Ebastine 10 mg Tablets
✔️ WHO-GMP Certified Allergy Medicine Manufacturer in India
✔️ Export-Quality Antihistamine Tablets Supplier
✔️ Reliable Manufacturer for ENT & Respiratory Segment Products

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.

AFTERAX-10 is a clinically effective anti-allergic formulation designed to provide rapid and sustained relief from allergic conditions and associated itching. It helps control hypersensitivity reactions while improving patient comfort and quality of life.

Manufactured in a WHO-GMP-certified facility under stringent quality control systems, AFTERAX-10 ensures high purity, optimal bioavailability, and consistent therapeutic performance. The product is ideally positioned for PCD Pharma Franchise, third-party manufacturing, and regulated export markets.

• Blocks histamine (H1) receptors responsible for allergic symptoms

• Reduces itching, redness, swelling, and skin irritation

• Controls sneezing, watery eyes, and runny nose

• Provides effective relief from skin itching and rashes

• Helps calm hypersensitive skin reactions

• Improves comfort in acute and chronic allergic conditions

• Effective relief from allergic rhinitis and urticaria

• Reduces itching, redness, and skin irritation

• Controls sneezing and watery nasal discharge

• Suitable for acute and chronic allergy management

• Once or twice daily dosing (as prescribed)

• High-quality API and excipients

• WHO-GMP-certified manufacturing standards

• Stable packaging for extended shelf life

• Ideal for domestic and export markets

• PCD Pharma Franchise & third-party manufacturing ready

• Allergic rhinitis

• Urticaria (hives)

• Skin allergies and rashes

• Pruritus (itching)

• Hypersensitivity reactions

• Dose: As directed by the physician

• Usually administered once or twice daily

• Swallow with water

• Follow prescribed duration for best results

• Mild drowsiness (depending on formulation)

• Dry mouth

• Headache

• Gastrointestinal discomfort (rare)

• Clinically trusted anti-allergic therapy

• Reliable symptom control with good tolerability

• Strict quality assurance and manufacturing compliance

• Suitable for long-term allergy management

• Strong franchise and export potential

Ideal for partners seeking:

• Anti-allergic tablet PCD Franchise

• Third-party manufacturing of antihistamine tablets

• WHO-GMP-certified allergy care manufacturer

• Export-ready anti-allergic formulations

DRESCAP-M is a clinically effective anti-allergic combination formulated with Desloratadine 5 mg + Montelukast 10 mg, designed for comprehensive management of allergic rhinitis and associated respiratory allergic conditions. It delivers dual-action relief by targeting both histamine and leukotriene pathways, ensuring superior symptom control and improved patient outcomes.

Manufactured in a WHO-GMP compliant facility using high-quality APIs and pharmacopeial-grade excipients, DRESCAP-M ensures consistent potency, optimal bioavailability, and reliable therapeutic efficacy — making it ideal for PCD Pharma Franchise, third-party manufacturing, and export markets.

Desloratadine (5 mg):
A second-generation, non-sedating H1-receptor antagonist that blocks histamine activity, reducing sneezing, runny nose, nasal itching, watery eyes, and skin irritation.

Montelukast (10 mg):
A selective leukotriene receptor antagonist (LTRA) that inhibits cysteinyl leukotriene receptors in the airways. Leukotrienes are inflammatory mediators responsible for nasal congestion, airway inflammation, and allergic symptoms.

The synergistic combination provides enhanced control of both early-phase (histamine-mediated) and late-phase (leukotriene-mediated) allergic responses, making it particularly effective in persistent and moderate-to-severe allergic conditions.

✅ Dual-Action Formula: Antihistamine + Leukotriene Blocker
✅ Effective in Allergic Rhinitis with Nasal Congestion
✅ Reduces Sneezing, Itching & Runny Nose
✅ Supports Control of Allergy-Associated Cough
✅ Non-Sedating Daytime Relief
✅ Once-Daily Dosing (as prescribed)
✅ WHO-GMP Manufactured
✅ Suitable for PCD Pharma & Third-Party Manufacturing
✅ Export-Quality Standards

✔️ Seasonal allergic rhinitis
✔️ Perennial allergic rhinitis
✔️ Allergic rhinitis with nasal blockage
✔️ Patients with allergy-associated respiratory symptoms
✔️ General physicians, ENT specialists & pulmonologists
✔️ Pharmacies, distributors, stockists & international buyers

Additional Information:

• Production Capacity: Fully automated, ISO & USFDA-compliant 600,000 Sq. ft. plant with zero liquid & gas discharge facility
• Delivery Time: 45-60 days
• Packaging Details: Our packaging is designed to ensure maximum product safety, stability, and market appeal. We utilize high-quality raw materials (RM) and USFDA-approved packaging components, making our products ideal for export and third-party manufacturing. Key Features of Our Packaging: ✅ Attractive & Market-Differentiating Designs: Our products come with customizable branding and change parts, allowing businesses to create a distinct identity in the pharma market. ✅ Pharmaceutical-Grade Materials: We use high-density PET bottles, tamper-evident caps, and premium blister foils to maintain product integrity. ✅ Advanced Protection: Our packaging is moisture-resistant, UV-protected, and oxidation-resistant, ensuring longer shelf life and stability. ✅ High-Precision Batch Coding & Labeling: We use laser batch coding, holographic labels, and serialized QR codes for authenticity and traceability. ✅ International Standards for Export: All our packaging materials meet USFDA, EUGMP, and WHO-GMP regulations, ensuring global compliance. Our packaging solutions help PCD Pharma companies, third-party manufacturers, and exporters differentiate their products in highly competitive markets while maintaining the highest pharmaceutical standards.